Cargando…
Easy access to α-ketoamides as SARS-CoV-2 and MERS M(pro) inhibitors via the PADAM oxidation route
SARS-CoV-2 caused worldwide the current outbreak called COVID-19. Despite multiple countermeasures implemented, there is an urgent global need for new potent and efficient antiviral drugs against this pathogen. In this context, the main protease (M(pro)) of SARS-CoV-2 is an essential viral enzyme an...
Autores principales: | Pelliccia, Sveva, Cerchia, Carmen, Esposito, Francesca, Cannalire, Rolando, Corona, Angela, Costanzi, Elisa, Kuzikov, Maria, Gribbon, Philip, Zaliani, Andrea, Brindisi, Margherita, Storici, Paola, Tramontano, Enzo, Summa, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575579/ https://www.ncbi.nlm.nih.gov/pubmed/36332546 http://dx.doi.org/10.1016/j.ejmech.2022.114853 |
Ejemplares similares
-
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination
por: Stefanelli, Irina, et al.
Publicado: (2023) -
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
por: Cannalire, Rolando, et al.
Publicado: (2020) -
Natural Compounds Inhibit SARS-CoV-2 nsp13
Unwinding and ATPase Enzyme Activities
por: Corona, Angela, et al.
Publicado: (2022) -
Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
por: Costanzi, Elisa, et al.
Publicado: (2021) -
Identification of Inhibitors of SARS-CoV-2
3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing
Screen
por: Kuzikov, Maria, et al.
Publicado: (2021)